Impact of an Artificial Intelligence Platform on Inappropriate Medication Use in Older Adults

Polypharmacy in the older adults is common and promotes the risk of drug interactions. The hypothesis evoked is that a virtual platform with artificial intelligence applied to the health, and in particular to the good use of the drug, could bring aids to the doctors them of the prescription of drugs. The main objective of this study is to evaluate the impact of geriatric use of the Synapse platform on the frequency of inappropriate medication prescriptions (STOPP criteria) in discharge orders for patients 65 years of age or older hospitalized in geriatric department.

* Inclusion criteria: * Male or female age aged more than 65 years * Hospitalization in geriatric department at Bordeaux University Hospital or Libourne Hospital * Initial drug prescription with at least 2 active pharmaceutical ingredients * Affiliation to French social security * Written informed consent signed by participant and investigator * Exclusion criteria: * Adults protected by law * Subject included in a clinical trial with an experimental treatment * Subject during exclusion period relative to another trial